GoodRx Holdings Inc
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
GDRX$3.65+4.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| (in thousands, except par values) | December 31, 2023 | December 31, 2022 |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $672,296 | $757,165 |
| Accounts receivable, net | 143,608 | 117,141 |
| Prepaid expenses and other current assets | 56,886 | 45,380 |
| Total current assets | 872,790 | 919,686 |
| Property and equipment, net | 15,932 | 19,820 |
| Goodwill | 410,769 | 412,117 |
| Intangible assets, net | 60,898 | 119,865 |
| Capitalized software, net | 95,439 | 70,072 |
| Operating lease right-of-use assets, net | 29,929 | 35,906 |
| Deferred tax assets, net | 65,268 | — |
| Other assets | 37,775 | 27,165 |
| Total assets | $1,588,800 | $1,604,631 |
| Liabilities and stockholders' equity | ||
| Current liabilities | ||
| Accounts payable | $36,266 | $17,700 |
| Accrued expenses and other current liabilities | 71,329 | 47,523 |
| Current portion of debt | 8,787 | 7,029 |
| Operating lease liabilities, current | 6,177 | 4,068 |
| Total current liabilities | 122,559 | 76,320 |
| Debt, net | 647,703 | 651,796 |
| Operating lease liabilities, net of current portion | 48,403 | 54,131 |
| Other liabilities | 8,177 | 7,557 |
| Total liabilities | 826,842 | 789,804 |
| Commitments and contingencies (Note 13) | ||
| Stockholders' equity | ||
| Preferred stock, $0.0001 par value; 50,000 shares authorized and zero shares issued and outstanding at December 31, 2023 and December 31, 2022 | — | — |
| Common stock, $0.0001 par value; Class A: 2,000,000 shares authorized, 92,355 and 83,293 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively; and Class B: 1,000,000 shares authorized, 301,732 and 313,732 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | 40 | 40 |
| Additional paid-in capital | 2,219,321 | 2,263,322 |
| Accumulated deficit | (1,457,403) | (1,448,535) |
| Total stockholders' equity | 761,958 | 814,827 |
| Total liabilities and stockholders' equity | $1,588,800 | $1,604,631 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.